Houston Wire & Cable Company (NASDAQ:HWCC):
Houston Wire & Cable Company (NASDAQ:HWCC) ended its previous trading session at $5.54 with the Loss of -0.36%. The company’s market cap is $91.24 Million, and the average volume is $40.89 Million. The 52-Week High range of the stock is $9.32, while the 52-week low range is $4.76. The Price to Sales (P/S) of the stock is 0.26, while P/B (Price to Book) stands at 0.92. When we look at the Volatility of the company, Week Volatility is at 4.45% whereas Month Volatility is at 5.97%.
According to 78.4 analysts, the Average Revenue Estimate for the current Fiscal quarter is $82.15 Million and the Low Revenue estimate is $4.78 Million, while the High Revenue estimate is $3.75 Million.
Houston Wire & Cable Company (NASDAQ:HWCC) analysts on average have given a price target of $8 on HWCC stock.
According to the Recommendation Trends of the stock polled by Zacks Investment Research for this month, the company has a consensus recommendation of 2 out of the scale from 1 to 5 where 1 stands for Strong Buy and 5 means Strong Sell.
Evelo Biosciences, Inc. (NASDAQ:EVLO):
Evelo Biosciences, Inc. (NASDAQ:EVLO) shares declined -3.21% and ended the day at $13.27. Its 52-week high and low range is between $16.75 and $6.51. The company’s outstanding shares are 31.98 Million. The volume of the company in the last trading session was 109516. The stock has a market cap of 424.37 Million. The Stock shows P/E value of 0 and Forward P/E of 0.
According to Finviz reported data, The SMA20 of the stock is at 4.43%, SMA50 is 24 percent, while SMA200 is 7.49%. The stock is currently has its Return on Assets (ROA) value of 0 Percent. The Return on Investment and Return on Equity (ROE) values are 0 percent and 0 percent, respectively.
The company’s ATR (Average True Range) is 1.51. The Weekly Volatility is 9.07% and the Monthly Volatility is 12.38%.
When we look at the Analyst Recommendations of the stock, the company has 0 rating given by Analysts where 1 stands for Strong Buy and 5 stands for Strong Sell.
Evelo Biosciences, Inc. (NASDAQ:EVLO) analysts on average have given a price target of $8 on EVLO stock.
Evelo Biosciences, Inc.’s Average Earnings Estimate for the current quarter is $-0.67, according to consensus of 1 analysts. The low EPS estimate is $-0.67, while the high EPS estimate is $-0.67.
Average Revenue Estimate of the company for the current Fiscal Quarter is $0, according to consensus of 1 analysts. The higher end of the revenue estimate is $0 and the lower end is $0.